MiniMed expands board to 11, adds Alcon CEO and Medtronic executive as directors

Filed June 29, 2026 · Period ending June 25, 2026 · ~1 min read

Key Changes

• high

  Board expanded from 9 to 11 directors, appointing Alcon CEO David Endicott and Medtronic SVP Linnea Burman effective June 29, 2026. Endicott joins as independent director on Compensation Committee; Burman represents Medtronic affiliate interest.

  Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation verify on EDGAR →
• high

  Burman will receive no board compensation while Medtronic remains a MiniMed affiliate, indicating significant ownership or control relationship between the two companies not detailed in this filing.

  Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation verify on EDGAR →
• low

  2026 annual meeting scheduled for October 9, 2026 (virtual), with August 11 record date. Stockholder proposal deadlines set for July 17 (bylaw nominations/business) and July 26 (Rule 14a-8 proposals).

  Item 8.01 — Other Events verify on EDGAR →